INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Upperton Capabilities Update April 2026: Fill/Finish
An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.
-
Advanced Isolator Tech Boosts Manufacturing Efficiency And Quality
Isolator technology can run continuously over several days, minimizing operator interaction and other opportunities to introduce contamination — ideal for high-volume, time-limited production runs.
-
De-Risking The Transition From Vial To Drug-Device Combination Product
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
Stopper Migration In Frozen Pre-Filled Syringes10/16/2024
Review a semi-automated method for dynamically assessing plunger migration under controlled variations in temperature and pressure, utilizing computer vision tools.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
How Can You Avoid Bioprocessing Risks When Using Cable Ties?10/15/2025
Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.
-
Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics5/9/2024
Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.
-
Robotics And Automation Addressing Production Shortages For Compounding Pharmacies9/11/2024
Drug shortages have increased the burden on compounding pharmacies. Robotics and automation can streamline processes, improve accuracy, and ensure quality to address challenges faced by these facilities.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
GMP drug product manufacturing supports solid dose and sterile parenteral development with formulation expertise, isolator fill‑finish, DEA‑licensed work, packaging, labeling, and supply‑chain services.
-
Stevanato Group vial forming lines come in a variety of specifications that vary depending on the production requirements. By maintaining close ties with the customer throughout every step of the process, we can design and manufacture fully tailored, purpose-built equipment capable of producing vials with entirely custom dimensions and shape.
-
HVLD is High Voltage Leak Detection, a sensitive, non-destructive technology to test container closure integrity in a variety of liquid-filled pharmaceutical and medical containers including glass vials and ampoules, IV-bags, Blow Fill Seal (BFS) bottles and cards and pre-filled syringes. HVLD can be used to conduct CCIT on any liquid-filled product as long as the container is made of electrically insulated material and it contains an electrically conductive solution.
-
Stevanato Group afterforming lines ensure the highest stability during transport to the annealing oven. The special material used for conveying preserves the cosmetic quality of the glass and its mechanical features. Each line is equipped with a cooling system, dimensional control devices and additional devices available on request.
-
A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on drug-specific performance.